Chargement en cours...
The potential role of TNFα in 2019 novel coronavirus pneumonia
The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with Ankylosing Spondylitis (AS), who was a biological agent (anti-TNFα) user in Wenzhou, China, and describe the clinical course and management of the case.
Enregistré dans:
| Publié dans: | Respir Med Case Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7215148/ https://ncbi.nlm.nih.gov/pubmed/32399393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101087 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|